Found: 12
Select item for more details and to access through your institution.
Biodistribution and tissue toxicity of amphotericin B in mice following multiple dose administration of a novel oral lipid-based formulation (iCo-009).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 12, p. 2610, doi. 10.1093/jac/dkq358
- By:
- Publication type:
- Article
Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation.
- Published in:
- 2010
- By:
- Publication type:
- Correction Notice
Visceral leishmaniasis affects liver and spleen concentrations of amphotericin B following administration to mice.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 3, p. 535, doi. 10.1093/jac/dkp465
- By:
- Publication type:
- Article
Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 64, n. 1, p. 101, doi. 10.1093/jac/dkp140
- By:
- Publication type:
- Article
ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29963-5
- By:
- Publication type:
- Article
The Effect of Digestion and Drug Load on Halofantrine Absorption from Self-nanoemulsifying Drug Delivery System (SNEDDS).
- Published in:
- AAPS Journal, 2016, v. 18, n. 1, p. 180, doi. 10.1208/s12248-015-9832-7
- By:
- Publication type:
- Article
Efficacy of an oral and tropically stable lipid-based formulation of Amphotericin B (iCo-010) in an experimental mouse model of systemic candidiasis.
- Published in:
- Lipids in Health & Disease, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-511X-12-158
- By:
- Publication type:
- Article
NLRP3 inflammasome activation drives bystander cone photoreceptor cell death in a P23H rhodopsin model of retinal degeneration.
- Published in:
- Human Molecular Genetics, 2016, v. 25, n. 8, p. 1501, doi. 10.1093/hmg/ddw029
- By:
- Publication type:
- Article
Discovery and Development of Toll-Like Receptor 4 (TLR4) Antagonists: A New Paradigm for Treating Sepsis and Other Diseases.
- Published in:
- Pharmaceutical Research, 2008, v. 25, n. 8, p. 1751, doi. 10.1007/s11095-008-9571-x
- By:
- Publication type:
- Article
Influence of Plasma Cholesterol and Triglyceride Concentrations and Eritoran (E5564) Micelle Size on its Plasma Pharmacokinetics and Ex Vivo Activity Following Single Intravenous Bolus Dose Into Healthy Female Rabbits.
- Published in:
- Pharmaceutical Research, 2008, v. 25, n. 1, p. 176, doi. 10.1007/s11095-007-9428-8
- By:
- Publication type:
- Article
Safety, pharmacokinetics and pharmacodynamics of four-hour intravenous infusions of eritoran in healthy Japanese and Caucasian men.
- Published in:
- Innate Immunity, 2012, v. 18, n. 6, p. 793, doi. 10.1177/1753425912441845
- By:
- Publication type:
- Article
Targeting adenocarcinoma and enzalutamide‑resistant prostate cancer using the novel anti‑androgen inhibitor ADA‑308.
- Published in:
- Oncology Reports, 2024, v. 52, n. 4, p. N.PAG, doi. 10.3892/or.2024.8791
- By:
- Publication type:
- Article